# Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

> **NCT02933905** · — · COMPLETED · sponsor: **Fundació Institut Germans Trias i Pujol** · enrollment: 38 (actual)

## Conditions studied

- Diabetic Macular Edema
- Vitreomacular Interface
- Anti-VEGF Treatment

## Interventions

- **DRUG:** Intravitreal Ranibizumab injection

## Key facts

- **NCT ID:** NCT02933905
- **Lead sponsor:** Fundació Institut Germans Trias i Pujol
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-01
- **Final completion:** 2016-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2016-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933905, "Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02933905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*